Euthymics Bioscience, Inc.'s Net Worth

$28.2 Million

Estimate Recalculated Sep 8, 2024 07:17PM EST

Who is Euthymics Bioscience, Inc.?

Euthymics Bioscience, Inc. has an estimated net worth of $28.2 Million. This is based on reported shares in DOV PHARMACEUTICAL INC.

SEC CIK

Euthymics Bioscience, Inc.'s CIK is 0001066833

Past Insider Trading and Trends

2005 was Euthymics Bioscience, Inc.'s most active year for acquiring shares with 19 total transactions. Euthymics Bioscience, Inc.'s most active month to acquire stocks was the month of January. 2004 was Euthymics Bioscience, Inc.'s most active year for disposing of shares, totalling 100 transactions. Euthymics Bioscience, Inc.'s most active month to dispose stocks was the month of July. 2003 saw Euthymics Bioscience, Inc. paying a total of $2,960,364.70 for 744,010 shares, this is the most they've acquired in one year. In 2006 Euthymics Bioscience, Inc. cashed out on 556,700 shares for a total of $8,264,479.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

DOV PHARMACEUTICAL INC No price found

SVP & CSO

Euthymics Bioscience, Inc. owns 25,000 units of Common Stock, 18,400 units of Common Stock, par value $.00001 per share, 120,465 units of Common Stock, par value $.0001 per share, 58,975 units of Common Share, par value $.0001 per share, 20,900 units of Common Stock, par valur $.0001 per share, 333,000 units of Stock Option under the 2000 Stock Option Plan, 325,000 units of Stock Options 2000 Grant Option Plan, 19,500 units of Common Stock 1998 Stock Option Plan, 21,000 units of common stock (right to buy 1998 option plan), 203,200 units of Stock Option (Right to buy), 69,300 units of Stock Options (Right to buy), 5,000 units of Common Stock, par value $0.0001 per share, 755,900 units of Common Stock, $0.0001 par value, 138,000 units of Title of Security. Euthymics Bioscience, Inc. used to own units in Common Stock, par value $.0000 per share but no longer holds any shares there.acquired a total of 673,760 shares in DOV PHARMACEUTICAL INC at a cost of $2,117,535.20, Euthymics also disposed a total of 1,932,383 shares of DOV PHARMACEUTICAL INC equalling to $30,304,560.35.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 16
Form 4
+263.16%
100K
$0.05
$5,300.00
138K
Apr 3
Form 4
+55.42%
13.8K
$0.07
$966.00
38.7K
Jan 9
Form 4
∞
25K
$0.20
$5,000.00
25K
Sep 7
Form 4
—
0
—
—
0
Aug 9
Form 3
—
0
—
—
0
Form 4
∞
5K
—
—
5K
May 22
Form 4
—
0
$11.07
-$165,770.00
0
Scheduled
Mar 1
Form 4
—
0
$11.29
-$654,597.00
25K
Scheduled
Feb 9 - Feb 13
Form 4
-41.90%
-316.70K
$18.00
-$5,700,632.00
439.2K
Scheduled
Feb 9
Form 4
—
0
$10.42
-$458,100.00
0
Scheduled
Feb 9
Form 4
—
0
—
—
0
Feb 7
Form 4
—
0
—
—
0
Feb 7
Form 4
—
0
—
—
0
Feb 7
Form 4
—
0
$10.57
-$262,280.00
0
Scheduled
Feb 3
Form 4
—
0
$9.30
-$65,200.00
0
Scheduled
Feb 1
Form 4
—
0
$9.32
-$130,800.00
0
Scheduled
Jan 10
Form 3
—
0
—
—
0
Form 4
—
0
$9.30
-$65,200.00
0
Scheduled
Nov 7
Form 4
-20.92%
-200.00K
$15.19
-$3,037,911.60
755.9K
Nov 2 - Nov 4
Form 4
—
0
$8.49
-$126,564.90
50.2K
Scheduled
Oct 17
Form 4
—
0
$9.83
-$70,500.00
0
Scheduled
Oct 3
Form 4
—
0
$9.30
-$65,200.00
0
Scheduled
Sep 7
Form 4
-3.37%
-33.30K
$18.00
-$599,400.00
955.9K
Scheduled
Aug 25
Form 4
—
0
$10.32
-$235,459.50
50.2K
Scheduled
Aug 15
Form 4
—
0
—
—
0
Jul 29
Form 4
—
0
$10.25
-$233,450.00
50.2K
Jun 27
Form 4
—
0
—
—
0
May 26
Form 4
—
0
—
—
0
May 26
Form 4
—
0
—
—
0
May 26
Form 4
—
0
—
—
0
May 26
Form 4
+6.46%
60K
—
—
989.2K
May 23
Form 4
—
0
$10.92
-$115,360.00
0
May 16
Form 4
∞
50K
$4.40
$220,000.00
50K
Mar 22
Form 4
—
0
—
—
0
Feb 1
Form 4
—
0
—
—
0
Feb 1
Form 4
—
0
—
—
0
Feb 1
Form 4
—
0
—
—
0
Feb 1
Form 4
—
0
—
—
0
Jan 6
Form 4
-29.49%
-21.00K
$16.46
-$345,660.00
50.2K
Nov 8
Form 4
-65.57%
-40.00K
$16.24
-$649,600.00
21K
Sep 20
Form 4
-10.42%
-100.00K
$16.18
-$1,618,370.00
859.25K
Sep 14 - Sep 15
Form 4
-22.18%
-264.83K
$15.22
-$4,030,219.70
929.2K
Aug 12 - Aug 13
Form 4
-6.30%
-64.48K
$15.24
-$982,721.70
959.25K
Aug 13
Form 4
-14.24%
-170.00K
$15.16
-$2,576,375.00
1.02M
Aug 12
Form 4
-2.40%
-35.17K
$15.48
-$544,283.64
1.43M
Aug 11
Form 4
—
0
$9.84
-$544,500.00
0
Aug 11 - Aug 12
Form 4
-2.45%
-30.00K
$15.42
-$462,600.00
1.19M
Aug 11
Form 4
—
0
—
—
0
Form 4
+7.97%
15K
$13.55
$203,250.00
203.2K
Jul 8
Form 4
+27.62%
15K
$13.55
$203,250.00
69.3K
Jul 8
Form 4
+14.12%
15K
$13.55
$203,250.00
121.2K
Jul 8
Form 4
-7.55%
-100.00K
$15.00
-$1,500,000.00
1.22M
Jun 4
Form 4
-24.69%
-20.00K
$15.11
-$302,200.00
61K
May 18
Form 4
-7.02%
-100.00K
$15.33
-$1,533,245.00
1.32M
May 12
Form 4
-23.53%
-6.00K
$17.63
-$105,770.90
19.5K
Apr 14
Form 4
-12.83%
-18.40K
$17.00
-$312,800.00
125K
Apr 12
Form 4
-2.40%
-8.00K
$17.15
-$137,200.00
325K
Apr 8
Form 4
-3.48%
-12.00K
$16.34
-$196,080.00
333K
Mar 24
Form 4
-5.19%
-20.00K
$16.30
-$326,000.00
365K
Mar 19
Form 4
-25.64%
-41.53K
—
—
120.47K
Mar 10
Form 4
-51.76%
-54.50K
$13.08
-$712,860.00
50.8K
Feb 27
Form 4
—
0
—
—
0
Feb 2
Form 4
—
0
—
—
0
Feb 2
Form 4
—
0
—
—
0
Feb 2
Form 4
—
0
—
—
0
Feb 2
Form 4
—
0
—
—
0
Feb 2
Form 3
—
0
—
—
0
Form 3
—
0
—
—
0
Form 4
+88.04%
18.4K
$8.24
$23,852.00
39.3K
Jan 26
Form 4
—
0
—
—
0
Jan 14
Form 4
+51.60%
41.8K
$8.26
-$98,472.00
122.8K
Jan 13 - Jan 15
Form 4
—
0
$8.71
-$375,650.00
15K
Aug 29 - Dec 30
Form 4
-2.40%
-16.20K
$14.62
-$240,755.82
660.12K
Sep 3 - Sep 5
Form 4
—
0
$8.61
-$69,935.39
799
Sep 3
Form 4
—
0
$8.74
-$28,819.00
0
Aug 29 - Sep 2
Form 4
—
0
$8.49
-$84,210.00
0
Aug 28
No matching records found